Dyslipidaemia in diabetes mellitus. Review of the main lipoprotein abnormalities and their consequences on the development of atherogenesis

Diabetes and Metabolism

Volumn 25, Issue SUPPL. 3, 1999, Pages 32-40

  Verges B L ^a  

^a HÔPITAL DU BOCAGE   (France)

Author keywords

Diabetes mellitus; Lipids; Lipoproteins

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID TRANSFER PROTEIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ATHEROGENESIS; CONFERENCE PAPER; DIABETES MELLITUS; DYSLIPIDEMIA; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERLIPIDEMIA; INSULIN RESISTANCE; LIPID OXIDATION; LIVER CLEARANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN GLYCOSYLATION;

ARTERIOSCLEROSIS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERLIPIDEMIAS; INSULIN; LIPOPROTEINS;

EID: 0033066771     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (85)

1. Stamler J, Vaccaro O, Neaton JD, Wenworth D. For the multiple risk factor intervention trial research group. Diabetes other risk factors and 12 year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care, 1993, 16, 434-444.
2. Wingard DL, Barrett-Connor E. Heart disease and diabetes. In : Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH, eds. Diabetes in America. Bethesda : National Institute of Health, 1995, 429-448.
3. Bierman EL. Atherogenesis in diabetes. Arterio Thromb, 1992, 12, 647-656.
4. Scanu AM, Fless GM. Lipoprotein(a) : heterogeneity and biological relevance. J Clin Invest, 1990, 85, 1709-1715.
5. Lagrost L. Regulation of cholesteryl ester transfer protein (CETP) activity : review of in vitro and in vivo studies. Biochim Biophys Acta, 1994, 215, 209-236.
6. Lagrost L, Desrumaux C, Masson D, Deckert V, Gambert P. Structure and function of plasma phospholipid transfer protein. Curr Opin Lipidol, 1998, 9, 203-209.
7. Chait A, Bierman EL, Albers JJ. Low density lipoprotein receptor activity in cultured skin fibroblasts. J Clin Invest, 1979, 64, 1309-1319.
8. Mazzone T, Foster D, Chait A. In vivo stimulation of low density lipoprotein degradation by insulin. Diabetes, 1984, 33, 333-338.
9. Baynes C, Hendersen AD, Richmond W, Johnston DG, Elkeles RS. The response of hepatic lipase and serum lipoproteins to acute hyperinsulinemia in Type 2 diabetes. Eur J Clin Invest, 1992, 22, 341-346.
10. Howard BV. Lipoprotein metabolism in diabetes mellitus. J Lipid Res, 1987, 28, 613-628.
11. Reaven GM. Abnormal lipoprotein metabolism in non insulin-dependent diabetes mellitus. Am J Med 1987, 83 (suppl. 3A), 31-40.
12. Taskinen MR. Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus. Diabetes, 1992, 41 (suppl. 2), 12-17.
13. Howard BV, Howard WJ. Dyslipidemia in non insulin-dependent diabetes mellitus. Endocrine Rev, 1994, 15, 263-274.
14. Tomkin GH, Owens D. Insulin and lipoprotein metabolism with special reference to the diabetic state. Diabetes/Metab Rev, 1994, 10, 225-252.
15. Howard BV. Pathogenesis of diabetic dyslipidemia. Diabetes Rev, 1995, 3, 423-432.
16. Lopes-Virella MF, Klein RL, Virella G. Modification of lipoproteins in diabetes. Diabetes/Metab Rev, 1996, 12, 69-90.
17. Harris Ml. Hypercholesterolemia in diabetes and glucose intolerance in the US population. Diabetes Care, 1991, 14, 366-374.
18. Laakso M. Epidemiology of diabetic dyslipidemia. Diabetes Rev, 1995, 3, 408-422.
19. UK Prospective Diabetes Study group. Plasma lipids and lipoproteins at diagnosis of NIDDM by age and sex (UK PDS 27). Diabetes Care, 1997, 20, 1683-1687.
20. Patti L, Swinburn B, Riccardi G, Rivellese AA, Howard BV. Alterations in very low density subfractions in normotriglyceridemic non insulin dependent diabetics. Atherosclerosis, 1991, 91, 15-23.
21. Steiner G. The dyslipoproteinemias of diabetes. Atherosclerosis, 1994, 110 (suppl.), 27-33.
22. Steiner G, Tkac I, Uffelman KD, Lewis GF. Important contribution of lipoprotein particle number to plasma triglyceride concentration in type 2 diabetes. Atherosclerosis, 1998, 137, 211-214.
23. Kissebah AH, Alfarsi S, Evans DJ, Adams PW. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein B kinetics in non insulin dependent diabetes mellitus. Diabetes, 1982, 31, 217-225.
24. Reaven GM, Greenfield DS. Diabetic hypertriglyceridemia. Evidence for three clinical syndromes. Diabetes, 1981, 30 (suppl. 2), 66-75.
25. Tobey TA, Greenfield DS, Kramer F, Reaven GM. Relationship between insulinresistance, insulin secretion, very low density lipoprotein kinetics and plasma triglyceride levels in normotriglyceridemic man. Metabolism, 1981, 30, 165-171.
26. Lewis GF, Uffelman KD, Szeto LW, Steiner G. Effects of acute hyperinsulinemia on VLDL-triglyceride and VLDL apoB production in normal weight and obese individuals. Diabetes, 1993, 42, 933-842.
27. Malmström R, Packard LJ, Caslake M et al. Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM. Diabetologia, 1997, 40, 454-462.
28. Howard BV, Abbott WG, Beltz WF, et al. Integrated study of low density lipoprotein metabolism and very low density lipoprotein metabolism in non insulin dependent diabetes. Metabolism, 1987, 36, 870-877.
29. Taskinen MR, Beltz WF, Harper I, et al. The effects of non insulin-dependent diabetes mellitus on VLDL triglycéride and VLDL apoB metabolism : studies before and after sulfonlyurea therapy. Diabetes, 1986, 35, 1268-1277.
30. Taskinen MR, Nikkila EA, Kuusi T, Harno K. Lipoprotein lipase activity and serum lipoproteins in untreated type 2 diabetes associated with obesity. Diabetologia, 1982, 22, 46-50.
31. Schonfeld G, Birge C, Miller JP, Kessler G, Santiago J. Apolipoprotein B levels and altered lipoprotein composition in diabetes. Diabetes, 1974, 23, 827-834.
32. Weisweiler P, Schwandt P. Type 1 (insulin-dependent) versus type 2 (non-insulin-dependent) diabetes mellitus : characterization of serum lipoprotein alterations. Eur J Clin Invest, 1987, 17, 87-91.
33. Klein RL, Lyons TJ, Lopes-Virella MF. Metabolism of very low and low-density lipoproteins isolated from normolipidaemic type 2 (non insulin dependent) diabetic patients by human monocyte-derived macrophages. Diabetologia, 1990, 33, 299-305.
34. Curtiss LK, Witzum JL. Plasma apolipoproteins AI, AII, B CI and E are glucolylated in hyperglycemic diabetic subjects. Diabetes, 1985, 34, 452-461.
35. Mamo JCL, Szeto L, Steiner G. Glycation of very low density lipoprotein from rat plasma impairs its catabolism. Diabetologia, 1990, 33, 339-342.
36. Saheki S, Hitsumoto Y, Murase M, Takeuchi N, Uchida K. In vitro degradation of very low density lipoprotein from diabetic patients by lipoprotein lipase. Clin Chim Acta, 1993, 217, 105-114.
37. Taskinen MR, Harno K, Nikkila EA. Serum lipids and lipoproteins in type 2 diabetes. Acta Endocrinologica, 1984 (suppl.), 262, 95-99.
38. Huuponen RK, Viikari JS, Saarimaa H. Correlation of serum lipids with diabetes control in sulfonylurea treated diabetic patients. Diabetes Care, 1984, 7, 575-578.
39. Witzum JL, Mahoney EM, Bronks MJ, et al. Non enzymatic glucosylation of low density lipoprotein alters ils biologic activity. Diabetes, 1982, 31, 283-291.
40. Feingold KR, Grunfeld C, Pang M, Doerrler W, Krauss RM. LDL subclass phenotypes and triglyceride metabolism in non insulin dependent diabetes. Arterioscler Thromb, 1992, 12, 1496-1502.
41. Haffner SM, Mykkanen L, Stern MP, Paidi M, Howard BV. Greater effect of diabetes on LDL size in women than in man. Diabetes Care, 1994, 17, 1164-1171.
42. Lamdenpera S, Sane T, Vuorinen-Markkola H, Knudsen P, Taskinen MR. LDL particle sizes in midly hypertriglyceridemic subjects : no relation to insulin-resistance or diabetes. Atherosclerosis, 1995, 113, 227-236.
43. Okumara K, Matsui H, Kawakami K, et al. Low density lipoprotein particle size is associated with glycosylated hemoglobin levels regardless of plasma lipids. Intern Med, 1998, 37, 273-279.
44. Austin MA, King MC, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype : a proposed genetic marker for coronary heart disease risk. Circulation, 1990, 82, 495-506.
45. De Graaf J, Hak-Lemmers HLM, Hectors MPC, Demacker PNM, Hendricks JCM, Stalenhoef AFH. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb, 1991, 11, 298-306.
46. Bagdade JD, Buchmann WE, Kuusi T, Taskinen MR. Persistent abnormalities in lipoprotein composition in non insulin dependent diabetes after intensive insulin therapy. Arteriosclerosis, 1990, 10, 232-239.
47. Kim HJ, Kurup IV. Non enzymatic glycosylation of human plusma low density lipoprotein. Evidence for in vitro and in vivo glucosylation. Metabolism, 1982, 31, 348-353.
48. Steinbrecher UP, Witzum JL. Glucosylation of low density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism. Diabetes, 1984, 33, 130-134.
49. Lopes-Virella MF, Klein RL, Lyons TJ, Stevenson HC, Witzum JL. Glycosylation of low-density lipoprotein enhances cholesteryl ester synthesis in human monocyte-derived macrophages. Diabetes, 1988, 37, 550-557.
50. Hunt JV, Smith CCT, Wolff SP. Autointoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes, 1990, 39, 1420-1424.
51. Mullarkey CJ, Edelstein D, Brownlee M. Free radicals generation by early glycation products : a mechanism for accelerated atherogenesis in diabetes. Biochim Biophys Res Comm, 1990, 173, 932-939.
52. Farnier M, Vergès B, Gambert Ph, Vaillant-Piard G, Bidan Y, Brun JM. High density lipoprotein distributionin type 2 (non insulin dependent) diabetes mellitus. Diabetologia, 1986, 29, 235A-236A.
53. Vergès B, Brun JM, Vaillant G, et al. Influence of obesity and hypertriglyceridemia on low HDL2-cholesterol level and its relationship with prevalence of atherosclerosis in type 2 diabetes. Diabete Metab, 1992, 18, 289-297.
54. Golay A, Zech L, Shi MZ, et al. High density lipoprotein (HDL) metabolism in non insulin dependent diabetes mellitus : measurement of HDL turn-over using tritiated HDL. J Clin Endocrinol Metab, 1987, 65, 512-518.
55. Harno K, Nikkila EA, Kuusi T. Plasma HDL-cholesterol and postheparin plasma hepatic endothelial lipase activity : relationship to obesity and non insulin dependent diabetes. Diabetologia, 1980, 19, 281.
56. Fielding CJ, Reaven GM, Fielding PE. Human non-insulin dependent diabetes : identification of a defect in plasma cholesterol transport normalized in vivo by insulin and in vitro by selective immunoabsorption of apolipoprotein E. Proc Natl Acad Sci U.S.A., 1998, 79, 6365-6369.
57. Briones ER, Mao SJT, Palumbo PJ, et al. Analysis of plasma lipids and apolipoproteins in insulin-dependent and non insulin-dependent diabetics. Metabolism, 1984, 33, 42-49.
58. Clay MA, Newnham HH, Barter PJ. Hepatic lipase promotes a loss of apolipoprotein A-I from triglyceride-enriched human high density lipoproteins during incubation in vitro. Arterioscl Thromb, 1991, 11, 415-422.
59. Caste C, Kuiper S, Blake W, Paigen B, Marotti K, Melchior G. Remodeling of the HDL in NIDDM a fundamental role for cholesteryl ester transfer protein. Am J Physiol, 1998, 274, E1091-1098.
60. Calvo C, Talussot C, Ponsin G, Berthezène F. Non enzymatic glycation of apolipoprotein A1. Effects on its self-association and lipid binding properties. Biochem Biophys Res Commun, 1988, 533, 1060-1067.
61. Duell PB, Oram JF, Bierman EL. Non enzymatic glycosylation of HDL resulting in inhibition of high-affinity binding to cultured human fibroblasts. Diabetes, 1990, 59, 1257-1263.
62. Haffner SM, Morales PA, Stern MP, Gruber MK. Lp(a) concentrations in NIDDM. Diabetes, 1992, 41, 1267-1272.
63. Csaszar A, Dieplinger H, Sandholzer C, et al. Plasma lipoprotein(a) concentration and phenotypes in diabetes mellitus. Diabetologia, 1993, 36, 47-51.
64. Hiraga T, Kobayashi T, Okubo M, et al. Prospective study of Lipoprotein(a) as a risk factor for atherosclerotic cardiovascular disease in patients with diabetes. Diabetes Care, 1995, 18, 241-244.
65. Ruiz J, Thillet J, James RW, et al. Association of elevated lipoprotein(a) levels and coronary heart disease in NIDDM patients. Relationship with apolipoprotein(a) phenotypes. Diabetologia, 1994, 37, 585-591.
66. Ahnadi CE, Masmoudi T, Berthezène F, Ponsin G. Decreased ability of high density lipoproteins to transfer cholesterol esters in non insulin-dependent diabetes mellitus. Eur J Clin Invest, 1993, 23, 459-465.
67. Bagdade JD, Lane JT, Subbaiah PV, Otto ME, Ritter MC. Accelerated cholesteryl ester transfer in non insulin-dependent diabetes mellitus. Atherosclerosis, 1993, 104, 69-77.
68. Riemens S, Vantoll A, Sluiter W, Dullaart R. Elevated plasma cholesteryl ester transfer in NIDDM relationships with apo B-containing lipoproteins and phospholipid transfer protein. Atherosclerosis, 1998, 140, 71-79.
69. Desrumaux C, Lagrost L, Vaillant G, Petit JM, Rudoni S, Brun JM, Gambert Ph, Vergès B. Phospholipid transfer protein (PLTP) mass concentration in NIDDM. Diabetologia, 1998, 41 (suppl. 1), A17.
70. Zilversmit DB. Atherogenesis a post prandial phenomenon. Circulation, 1979, 60, 473-785.
71. Chen I, Swami S, Skowronski R, Coulston A, Reaven GM. Differences in post prandial lipemia between patients with normal glucose tolerance and non insulin dependent diabetes mellitus. J Clin Endocrinol Metab, 1993, 76, 172-177.
72. Lewis GF, O'Meara NM, Solstys PA, et al. Fasting hypertriglyceridemia in non insulin-dependent diabetes mellitus is an important pedictor of post-prandial lipid and lipoprotein abnormalities. J Clin Endocrinol Metab, 1991, 72, 934-944.
73. Schrezenmeir J, Keppler J, Fenselau S, et al. The phenomenon of a high triglyceride response to an oral lipid load in healthy subjects and its link to the metabolic syndrome. Ann N Y Acad Sci, 1993, 683, 302-314.
74. Jeppesen J, Hollenbeck CB, Zhou MY, et al. Relation between insulin resistance, hyperinsulinemia, post heparin plasma lipoprotein lipase activity and post-prandial lipemia. Arterioscl, Thromb, 1993, 15, 320-324.
75. Jenkins AJ, Steele JJ, Janus ED, Best JD. Increased plasma apolipoprotein(a) levels in IDDM patients with microalbuminuria. Diabetes, 1991, 40, 787-790.
76. Rivellese A, Ricardi G, Romano G, et al. Presence of very low density lipoprotein compositional abnormalities in type 1 (insulin-dependent) diabetic patients : effects of blood glucose optimisation. Diabetologia, 1988, 31, 884-888.
77. Klein RL, Lyons IM, Lopes-Virella MR. Interaction of very low density lipoprotein isolated from type 1 (insulin-dependent) diabetic subjects with human monocyte-derived macrophages. Metabolism, 1989, 38, 1108-1114.
78. James R, Pometta D. Differences in lipoprotein subfraction composition and distribution between type 1 diabetes and control subjects. Diabetes, 1990, 39, 1158-1164.
79. Lyons TJ, Klein RL, Baynes JW, Stevenson HC, Lopes-Virella MF. Stimulation of cholesteryl ester synthesis in human monocyte-derived macrophages by low density lipoproteins from type 1 (insulin-dependent) diabetic patients influence of non enzymatic glycation of low density lipoprotein. Diabetologia, 1987, 30, 916-923.
80. Bagdade JD, Helve E, Taskinen MR. Effects of continuous insulin infusion therapy on lipoprotein surface and core lipid composition in insulin-dependent diabetes mellitus. Metabolism, 1991, 40, 445-449.
81. Eckel RH, Albers JJ, Chering MC, et al. High density lipoprotein composition in insulin dependent diabetes mellitus. Diabetes, 1981, 30, 132-138.
82. Dullaart RP, Groener EM, Dickeschei BD, Erkelens W, Doorenbos M. Elevated cholelsteryl ester transfer protein activity in type 1 diabetic men who smoke. Diabetes Care, 1991, 14, 338-341.
83. Bagdade JD, Ritter MC, Subbaiah PV. Accelerated cholesteryl ester transfer in plasma of patients with insulin dependent diabetes mellitus. Eur J Clin Invest, 1991, 21, 161-167.
84. Ruotolo G, Parlavecchia M, Taskinen MR, et al. Normalization of lipoprotein composition by intraperitoneal insulin in IDDM. Diabetes Care, 1994, 17, 6-12.
85. Bagdade JD, Dunn FL, Eckel RH, Ritter MC. Intraperitoneal insulin therapy corrects abnormalities in cholesteryl ester transfer and lipoprotein lipase activities in insulin dependent diabetes Mellitus. Arterioscler Thromb, 1994, 14, 1933-1939.